Granowitz Craig B (CIK 1876655) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-03). Recent activity: Buy LXRX (35,790 shares), Buy LXRX (74,226 shares), Buy LXRX (202,260 shares), Sell LXRX (109,098 shares), Buy LXRX (27,917 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-03 | LEXICON PHARMACEUTICALS, INC. (LXRX) | SVP, Chief Medical Officer | Buy | 35,790 | $0 |
| 2026-03-03 | LEXICON PHARMACEUTICALS, INC. (LXRX) | SVP, Chief Medical Officer | Buy | 74,226 | $0 |
| 2026-03-03 | LEXICON PHARMACEUTICALS, INC. (LXRX) | SVP, Chief Medical Officer | Buy | 202,260 | $0 |
| 2026-03-03 | LEXICON PHARMACEUTICALS, INC. (LXRX) | SVP, Chief Medical Officer | Sell | 109,098 | $160,374 |
| 2025-03-03 | LEXICON PHARMACEUTICALS, INC. (LXRX) | SVP, Chief Medical Officer | Buy | 27,917 | $0 |
| 2025-03-03 | LEXICON PHARMACEUTICALS, INC. (LXRX) | SVP, Chief Medical Officer | Buy | 35,790 | $0 |
| 2025-03-03 | LEXICON PHARMACEUTICALS, INC. (LXRX) | SVP, Chief Medical Officer | Buy | 74,227 | $0 |
| 2025-03-03 | LEXICON PHARMACEUTICALS, INC. (LXRX) | SVP, Chief Medical Officer | Sell | 65,308 | $43,756 |
Source: SEC Form 4 filings · as of 2026-03-03